4//SEC Filing
Daly Jason B. 4
Accession 0001628280-24-008977
CIK 0001723128other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:54 PM ET
Size
19.0 KB
Accession
0001628280-24-008977
Insider Transaction Report
Form 4
Daly Jason B.
EVP, Chief Legal Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-03-03+22,645→ 37,126 total - Tax Payment
Class A Common Stock
2024-03-03$5.47/sh−7,166$39,198→ 29,960 total - Exercise/Conversion
Class A Common Stock
2024-03-03+38,226→ 68,186 total - Tax Payment
Class A Common Stock
2024-03-03$5.47/sh−10,864$59,426→ 57,322 total - Exercise/Conversion
Restricted Stock Units
2024-03-03−22,645→ 45,290 total→ Class A Common Stock (22,645 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-03−38,226→ 114,679 total→ Class A Common Stock (38,226 underlying) - Award
Restricted Stock Units
2024-03-04+143,519→ 143,519 total→ Class A Common Stock (143,519 underlying) - Award
Performance-Based Restricted Stock Units
2024-03-04+287,038→ 287,038 total→ Class A Common Stock (287,038 underlying)
Footnotes (8)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]On March 3, 2022, the reporting person was granted 90,580 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- [F5]On March 3, 2023, the reporting person was granted 152,905 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- [F6]The restricted stock units vest in four equal annual installments beginning on March 4, 2025.
- [F7]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F8]Represents a performance-based restricted stock unit grant of 143,519 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2027, the last day of the performance period.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001906486
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:54 PM ET
- Size
- 19.0 KB